BRIEF published on 07/30/2025 at 08:50, 7 months 23 days ago Exosens Releases 2025 Half-Year Financial Report Innovation Financial Report Electro-optical Technologies Exosens 2025
BRIEF published on 07/30/2025 at 08:50, 7 months 23 days ago Exosens publie son rapport financier semestriel 2025 Innovation Rapport Financier Exosens 2025 Technologies Électro-optiques
PRESS RELEASE published on 07/30/2025 at 08:45, 7 months 23 days ago Exosens announces the publication of its 2025 half-year financial report Exosens announces the publication of its 2025 half-year financial report. The report is available on the company's website. Exosens is an innovator in optoelectronics French Financial Markets Authority Exosens Optoelectronics 2025 Half-year Financial Report Innovator
BRIEF published on 05/26/2025 at 17:50, 9 months 26 days ago Exosens Shareholders Approve Key Resolutions at General Meeting Governance General Meeting Exosens Dividends 2024 Financials
BRIEF published on 05/26/2025 at 17:50, 9 months 26 days ago Les actionnaires d'Exosens approuvent les résolutions clés lors de l'assemblée générale Gouvernance Assemblée Générale Exosens Dividendes Résultats Financiers 2024
PRESS RELEASE published on 05/26/2025 at 17:45, 9 months 26 days ago Exosens: Combined General Meeting of 23 May 2025 Exosens shareholders approve 2024 financial statements and dividend payment at the Combined General Meeting on 23 May 2025 in France Shareholders Financial Statements Governance Exosens Dividends
BRIEF published on 04/28/2025 at 07:35, 10 months 24 days ago Exosens annonce une forte croissance de son chiffre d'affaires au premier trimestre 2025, portée par la demande du secteur de la défense Croissance Des Revenus Marché De La Défense Intensificateurs D'image Acquisition De Noxant Marge Brute Ajustée
BRIEF published on 04/28/2025 at 07:35, 10 months 24 days ago Exosens Reports Robust Q1 2025 Revenue Growth Driven by Defense Demand Revenue Growth Defense Market Image Intensifiers Noxant Acquisition Adjusted Gross Margin
PRESS RELEASE published on 04/28/2025 at 07:30, 10 months 24 days ago Exosens delivers strong revenue growth in Q1 2025 in a dynamic defense market environment; Fully on track to 2025 guidance Exosens reports strong revenue growth of 21.1% to €104.9m in Q1 2025 in the defense market. Adjusted gross margin up 28.1% to €52.6m, fully on track to 2025 guidance Revenue Growth Exosens Defense Market 2025 Guidance Adjusted Gross Margin
Published on 03/20/2026 at 13:30, 2 days ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 1 hour ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/22/2026 at 12:23, 1 hour 18 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 1 day 14 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 16 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 16 hours ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 1 day 16 hours ago BRP Unveils the Winners of its 6th International Design Challenge
Published on 03/20/2026 at 19:00, 1 day 18 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 1 day 18 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 1 day 19 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 1 day 19 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA